Yousif Capital Management LLC Sells 145 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Yousif Capital Management LLC decreased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 1.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,878 shares of the medical instruments supplier’s stock after selling 145 shares during the quarter. Yousif Capital Management LLC’s holdings in LeMaitre Vascular were worth $726,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in LMAT. Townsquare Capital LLC lifted its position in LeMaitre Vascular by 38.0% during the 3rd quarter. Townsquare Capital LLC now owns 47,953 shares of the medical instruments supplier’s stock worth $4,454,000 after buying an additional 13,210 shares in the last quarter. Barclays PLC boosted its stake in LeMaitre Vascular by 394.5% during the 3rd quarter. Barclays PLC now owns 36,577 shares of the medical instruments supplier’s stock worth $3,396,000 after acquiring an additional 29,180 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of LeMaitre Vascular by 6.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 191,511 shares of the medical instruments supplier’s stock valued at $17,789,000 after buying an additional 11,395 shares during the period. Creative Planning raised its position in shares of LeMaitre Vascular by 20.7% during the third quarter. Creative Planning now owns 3,594 shares of the medical instruments supplier’s stock worth $334,000 after purchasing an additional 617 shares during the period. Finally, Copeland Capital Management LLC boosted its holdings in shares of LeMaitre Vascular by 1.0% in the third quarter. Copeland Capital Management LLC now owns 1,163,392 shares of the medical instruments supplier’s stock valued at $108,068,000 after buying an additional 11,318 shares during the period. Institutional investors own 84.64% of the company’s stock.

Analyst Upgrades and Downgrades

LMAT has been the topic of several research reports. Barrington Research boosted their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a research note on Friday, November 1st. StockNews.com cut shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Friday, December 13th. Oppenheimer reaffirmed an “outperform” rating and issued a $93.00 price objective (up from $90.00) on shares of LeMaitre Vascular in a report on Friday, November 1st. Finally, Wells Fargo & Company began coverage on LeMaitre Vascular in a report on Thursday. They issued an “equal weight” rating and a $95.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.63.

LeMaitre Vascular Stock Up 1.7 %

Shares of LMAT opened at $98.65 on Friday. The stock has a market cap of $2.22 billion, a PE ratio of 53.91, a PEG ratio of 2.19 and a beta of 0.96. The business has a 50-day simple moving average of $95.94 and a two-hundred day simple moving average of $93.61. LeMaitre Vascular, Inc. has a 12-month low of $59.87 and a 12-month high of $109.58.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.